City of Hope has long been a leader in cancer research, including colorectal cancers. We are currently conducting multiple clinical trials of new chemotherapy drugs and other agents that may improve outcomes for patients with regionally metastatic and advanced disease, and prevent recurrence after treatment of early colorectal cancer.
Through our research program, patients gain access to promising new anticancer drugs and technologies that are not available to the general public. As a patient at City of Hope, you may qualify to participate in a test of these new investigational therapies.
To learn more about our clinical trials program and specifically about trials for colorectal cancer, click here.